Published in Mol Pharmacol on November 16, 2009
Epigenetic suppression of GAD65 expression mediates persistent pain. Nat Med (2011) 2.17
A role for repressive histone methylation in cocaine-induced vulnerability to stress. Neuron (2011) 1.92
HDAC inhibitor-based therapies: can we interpret the code? Mol Oncol (2012) 1.67
The dynamics of DNA methylation in schizophrenia and related psychiatric disorders. Neuropsychopharmacology (2012) 1.40
Structure, mechanism, and inhibition of histone deacetylases and related metalloenzymes. Curr Opin Struct Biol (2011) 1.35
Setdb1 histone methyltransferase regulates mood-related behaviors and expression of the NMDA receptor subunit NR2B. J Neurosci (2010) 1.33
Clinical and experimental applications of sodium phenylbutyrate. Drugs R D (2011) 1.32
Histone deacetylases (HDAC)-induced histone modifications in the amygdala: a role in rapid tolerance to the anxiolytic effects of ethanol. Alcohol Clin Exp Res (2011) 1.18
Aberrant histone deacetylase2-mediated histone modifications and synaptic plasticity in the amygdala predisposes to anxiety and alcoholism. Biol Psychiatry (2013) 1.12
Crosstalk among Epigenetic Pathways Regulates Neurogenesis. Front Neurosci (2012) 1.10
Effect of valproic acid on mitochondrial epigenetics. Eur J Pharmacol (2012) 1.08
Disease- and age-related changes in histone acetylation at gene promoters in psychiatric disorders. Transl Psychiatry (2011) 0.97
Epigenetics-beyond the genome in alcoholism. Alcohol Res (2012) 0.94
New therapeutic targets for mood disorders. ScientificWorldJournal (2010) 0.94
Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders. Pharmacol Ther (2014) 0.92
Class I HDAC imaging using [ (3)H]CI-994 autoradiography. Epigenetics (2013) 0.92
Small molecule inhibitors of zinc-dependent histone deacetylases. Neurotherapeutics (2013) 0.91
HDAC inhibition imparts beneficial transgenerational effects in Huntington's disease mice via altered DNA and histone methylation. Proc Natl Acad Sci U S A (2014) 0.90
Interindividual Variability in Stress Susceptibility: A Role for Epigenetic Mechanisms in PTSD. Front Psychiatry (2013) 0.89
Valproic acid: an anticonvulsant drug with potent antinociceptive and anti-inflammatory properties. Naunyn Schmiedebergs Arch Pharmacol (2013) 0.87
Effects of histone deacetylase inhibitors on amygdaloid histone acetylation and neuropeptide Y expression: a role in anxiety-like and alcohol-drinking behaviours. Int J Neuropsychopharmacol (2014) 0.87
Epigenetic dysregulation in schizophrenia: molecular and clinical aspects of histone deacetylase inhibitors. Eur Arch Psychiatry Clin Neurosci (2013) 0.87
Targeting specific HATs for neurodegenerative disease treatment: translating basic biology to therapeutic possibilities. Front Cell Neurosci (2013) 0.86
Combination therapy: histone deacetylase inhibitors and platinum-based chemotherapeutics for cancer. Cancer Lett (2012) 0.86
Epigenetic mechanisms in schizophrenia. Dialogues Clin Neurosci (2014) 0.85
Histone deacetylase inhibitors as potential treatment for spinal muscular atrophy. Genet Mol Biol (2013) 0.84
A novel natural product inspired scaffold with robust neurotrophic, neurogenic and neuroprotective action. Sci Rep (2015) 0.83
Genome-wide screening for genes associated with valproic acid sensitivity in fission yeast. PLoS One (2013) 0.83
Antidepressant-like effect of sodium butyrate is associated with an increase in TET1 and in 5-hydroxymethylation levels in the Bdnf gene. Int J Neuropsychopharmacol (2014) 0.81
General Anesthesia Causes Epigenetic Histone Modulation of c-Fos and Brain-derived Neurotrophic Factor, Target Genes Important for Neuronal Development in the Immature Rat Hippocampus. Anesthesiology (2016) 0.80
Involvement of HDAC1 and HDAC3 in the Pathology of Polyglutamine Disorders: Therapeutic Implications for Selective HDAC1/HDAC3 Inhibitors. Pharmaceuticals (Basel) (2014) 0.80
Epigenetic regulation of persistent pain. Transl Res (2014) 0.80
Proteomic investigation of epigenetics in neuropsychiatric disorders: a missing link between genetics and behavior? J Proteome Res (2010) 0.80
Epigenetic management of major psychosis. Clin Epigenetics (2011) 0.79
Experience and the ever-changing brain: what the transcriptome can reveal. Bioessays (2014) 0.79
Pharmacotherapy for anxiety disorders in children and adolescents. Dialogues Clin Neurosci (2011) 0.78
Stressed and depressed? Check your GDNF for epigenetic repression. Neuron (2011) 0.78
Systematic analysis of time-series gene expression data on tumor cell-selective apoptotic responses to HDAC inhibitors. Comput Math Methods Med (2014) 0.77
Epigenetics in mental illness: hope or hype? J Psychiatry Neurosci (2010) 0.76
A steep learning curve: decoding epigenetic influence on behavior and mental health. Environ Health Perspect (2012) 0.76
Microbiota and Neurological Disorders: A Gut Feeling. Biores Open Access (2016) 0.76
The possibility of evidence-based psychiatry: depression as a case. Clin Epigenetics (2010) 0.75
Transcriptomic profiling of human hippocampal progenitor cells treated with antidepressants and its application in drug repositioning. J Psychopharmacol (2017) 0.75
Molecular biology research in neuropsychiatry: India's contribution. Indian J Psychiatry (2010) 0.75
The epigenetic regulation of HIF-1α by SIRT1 in MPP(+) treated SH-SY5Y cells. Biochem Biophys Res Commun (2016) 0.75
Effects of prenatal Poly I:C exposure on global histone deacetylase (HDAC) and DNA methyltransferase (DNMT) activity in the mouse brain. Mol Biol Rep (2016) 0.75
Lysine Acetylation and Deacetylation in Brain Development and Neuropathies. Genomics Proteomics Bioinformatics (2017) 0.75
Targeting New Candidate Genes by Small Molecules Approaching Neurodegenerative Diseases. Int J Mol Sci (2015) 0.75
A chemical strategy for the cell-based detection of HDAC activity. ACS Chem Biol (2014) 0.75
Reelin promoter hypermethylation in schizophrenia. Proc Natl Acad Sci U S A (2005) 3.12
On the epigenetic regulation of the human reelin promoter. Nucleic Acids Res (2002) 1.69
The human reelin gene: transcription factors (+), repressors (-) and the methylation switch (+/-) in schizophrenia. Pharmacol Ther (2006) 1.32
DNA methyltransferase 1 regulates reelin mRNA expression in mouse primary cortical cultures. Proc Natl Acad Sci U S A (2005) 1.26
Histone modifications, DNA methylation, and schizophrenia. Neurosci Biobehav Rev (2009) 1.17
Characterization of the action of antipsychotic subtypes on valproate-induced chromatin remodeling. Trends Pharmacol Sci (2008) 1.17
Growth arrest and DNA-damage-inducible, beta (GADD45b)-mediated DNA demethylation in major psychosis. Neuropsychopharmacology (2011) 1.17
Histone deacetylase inhibitors decrease reelin promoter methylation in vitro. J Neurochem (2005) 1.16
Dimethylated lysine 9 of histone 3 is elevated in schizophrenia and exhibits a divergent response to histone deacetylase inhibitors in lymphocyte cultures. J Psychiatry Neurosci (2009) 0.99
Histone deacetylase inhibitors and candidate gene expression: An in vivo and in vitro approach to studying chromatin remodeling in a clinical population. J Psychiatr Res (2009) 0.98
5-Lipoxygenase inhibitor MK-886 increases GluR1 phosphorylation in neuronal cultures in vitro and in the mouse cortex in vivo. Brain Res (2007) 0.98
Prenatal nutrition, epigenetics and schizophrenia risk: can we test causal effects? Epigenomics (2012) 0.97
GABAergic promoter hypermethylation as a model to study the neurochemistry of schizophrenia vulnerability. Expert Rev Neurother (2009) 0.96
From trans-methylation to cytosine methylation: evolution of the methylation hypothesis of schizophrenia. Epigenetics (2009) 0.96
Neurocognitive effects of repetitive transcranial magnetic stimulation in severe major depression. Clin Neurophysiol (2003) 0.94
Induction of the reelin promoter by retinoic acid is mediated by Sp1. J Neurochem (2007) 0.92
Minocycline increases phosphorylation and membrane insertion of neuronal GluR1 receptors. Neurosci Lett (2008) 0.91
Reduced baseline acetylated histone 3 levels, and a blunted response to HDAC inhibition in lymphocyte cultures from schizophrenia subjects. Schizophr Res (2008) 0.91
Histone methylation at H3K9: evidence for a restrictive epigenome in schizophrenia. Schizophr Res (2013) 0.88
Nicotine induces chromatin remodelling through decreases in the methyltransferases GLP, G9a, Setdb1 and levels of H3K9me2. Int J Neuropsychopharmacol (2012) 0.85
Subjective evaluations of research participation by persons with mental illness. J Nerv Ment Dis (2007) 0.83
Chromatin from peripheral blood mononuclear cells as biomarkers for epigenetic abnormalities in schizophrenia. Cardiovasc Psychiatry Neurol (2009) 0.80
Enhancement of psychotherapy using epigenetic modulating drugs. Med Hypotheses (2011) 0.77
Increasing neuronal 'stemness': chromatin relaxation and the expression of reprogramming genes in post-mitotic neurons. Med Hypotheses (2012) 0.76
Listening to Schneiderian Voices: A Novel Phenomenological Analysis. Psychopathology (2016) 0.76